Inventor · disambiguated record
Nicola Bisek
Also filed as: BISEK NICOLA
10 granted patents·15 pending applications·12 citations·filing 2012–2025
81Inventor score
Files withASCENDIS PHARMA AS16ASCENDIS PHARMA ONCOLOGY DIV A/S5ASCENDIS PHARMA OPHTHALMOLOGY DIV A/S2HERSEL ULRICH2
Top patents by PatentIndex Score
25 records- 0179US11642415B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2019·Granted May 9, 2023·1 cites·28 claims
- 0277US10729778B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2017·Granted Aug 4, 2020·1 cites·24 claims
- 0375US9561287B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2012·Granted Feb 7, 2017·3 cites·28 claims
- 0474US12246070B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2023·Granted Mar 11, 2025·0 cites·4 claims
- 0573US10519226B2VEGF neutralizing prodrugs for the treatment of ocular conditionsASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2013·Granted Dec 31, 2019·6 cites·21 claims
- 0664US9855340B2Hydrogel prodrugsASCENDIS PHARMA AS·Filed 2013·Granted Jan 2, 2018·1 cites·44 claims
- 0763US2025255973A1Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2025·Application pending·0 cites
- 0861US10040850B2Protecting group comprising a purification tagASCENDIS PHARMA AS·Filed 2014·Granted Aug 7, 2018·0 cites·14 claims
- 0952US2023241217A1Hydrogel irradiationASCENDIS PHARMA AS·Filed 2021·Application pending·0 cites
- 1050US2021330798A1Treatment of infectionsASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 1150US2018312582A1Protecting Group Comprising a Purification TagASCENDIS PHARMA AS·Filed 2018·Application pending·0 cites
- 1249US2021330807A1Novel hydrogel conjugatesASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 1349US2025387503A1Drug conjugates for the treatment of ocular disordersASCENDIS PHARMA OPHTHALMOLOGY DIV A/S·Filed 2025·Application pending·0 cites
- 1447US2023065814A1Conjugates of-electron-pair-donating heteroaromatic nitrogen-comprising compoundsASCENDIS PHARMA AS·Filed 2020·Application pending·0 cites
- 1547US2022304993A1Conjugates of an electron-donating nitrogen or tertiary amine comprising compoundsASCENDIS PHARMA AS·Filed 2020·Application pending·0 cites
- 1647US2022305129A1Conjugates of heteroaromatic nitrogen-comprising compoundsASCENDIS PHARMA AS·Filed 2020·Application pending·0 cites
- 1745US2022054476A1Sustained local drug levels for innate immune agonistsASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 1845US2022054478A1Minimization of systemic inflammationASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 1945US2022054477A1Induction of sustained local inflammationASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 2045US2023102309A1Tyrosine kinase inhibitor conjugatesASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 2144US2021008168A1ConjugatesASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
- 2242US11896671B2Conjugation method for carrier-linked prodrugsASCENDIS PHARMA AS·Filed 2017·Granted Feb 13, 2024·0 cites·24 claims
- 2342US2022062273A1Conjugates of pattern recognition receptor agonistsASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 2441US11298427B2Prodrugs comprising a pyroglutamate linkerASCENDIS PHARMA AS·Filed 2016·Granted Apr 12, 2022·0 cites·16 claims
- 2537US11633487B2Prodrugs comprising an aminoalkyl glycine linkerASCENDIS PHARMA AS·Filed 2015·Granted Apr 25, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Nicola Bisek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →